Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD300LG | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | TOR1B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | MVK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ATP6V1E1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | FUCA1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SCML2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KANSL3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GART | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MBNL2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | TBC1D8B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |